An Observational Study of Erlotinib (Tarceva) as Second-line Treatment in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Failure of Pemetrexed in First-line Therapy
Clinical trial NCT01664533 · COMPLETED
Trial details
- NCT number
- NCT01664533
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-09-01
- Primary completion
- 2013-08-01
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.